Skip Navigation


International Immunology Advance Access originally published online on March 18, 2005
International Immunology 2005 17(5):539-547; doi:10.1093/intimm/dxh232
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
17/5/539    most recent
dxh232v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Mende, I.
Right arrow Articles by Kufer, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mende, I.
Right arrow Articles by Kufer, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Japanese Society for Immunology. 2005. All rights reserved. For permissions, please e-mail: journals.permissions@oupjournals.org

Highly efficient antigen targeting to M-DC8+ dendritic cells via Fc{gamma}RIII/CD16-specific antibody conjugates

Ines Mende1, Patrick Hoffmann1, Andreas Wolf1, Ralf Lutterbüse1, Eugen Kopp2, Patrick A. Baeuerle1, Annegret de Baey3 and Peter Kufer1,2

1 Micromet AG, Staffelseestrasse 2, 81477 Munich, Germany
2 Institute for Immunology, Ludwig-Maximilians-University, Goethestrasse 31, 80336 Munich, Germany
3 Techno Venture Management, Maximilianstrasse 35C, 80539 Munich, Germany

Correspondence to: P. Kufer; E-mail: peter.kufer{at}micromet.de

Conjugates of peptide antigens with antibodies specifically recognizing surface molecules on dendritic cells (DC) represent an attractive approach to target antigens to antigen-presenting cells (APC) for the induction of specific T cell responses. The present study evaluates the potential of M-DC8+ DC, a sub-population of professional APC in the blood, for an antibody-based vaccination strategy. We prepared, by chemical cross-linking, conjugates of peptide model antigens with antibodies directed against different cell surface molecules of DC. Antigen–peptide conjugates using an anti-CD16 (Fc{gamma}RIII) antibody were most potent in inducing in vitro activation of a specific CD4+ T cell response. They were at least 300 times more efficient than two other antibody–antigen conjugates and ~500 times more efficient than unconjugated antigen peptides. Our data demonstrate that specific antigen targeting via CD16 on M-DC8+ DC is a promising vaccination approach for the efficient induction of specific CD4+ T cell responses ex vivo, and perhaps in vivo.

Keywords: antibodies, antigen presentation, dendritic cells, Fc receptors, vaccination

Transmitting editor: T. Huenig


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 haematolHome page
C. Talarn, A. Urbano-Ispizua, R. Martino, J. A. Perez-Simon, M. Batlle, C. Herrera, M. Granell, A. Gaya, M. Torrebadell, F. Fernandez-Aviles, et al.
Kinetics of recovery of dendritic cell subsets after reduced-intensity conditioning allogeneic stem cell transplantation and clinical outcome
Haematologica, December 1, 2007; 92(12): 1655 - 1663.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Bayry, S. Lacroix-Desmazes, M. D. Kazatchkine, O. Hermine, D. F. Tough, and S. V. Kaveri
Modulation of Dendritic Cell Maturation and Function by B Lymphocytes
J. Immunol., July 1, 2005; 175(1): 15 - 20.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.